News & Insights

Latest from Aurora Analytica

Case studies, publications, and company milestones from the team building the future of clinical trial strategy.

★ FeaturedCase StudyDecember 10, 2025

A Global CRO Streamlines Trial Strategy and Boosts RFP Quality with Aurora Analytica™

A prominent global CRO adopted Aurora Analytica™ to modernize its pre-award landscape analysis. After hands-on use across multiple projects, they rated the platform 10/10 for satisfaction.

10/10User Satisfaction
8/10Time Saving
9/10Cost Saving
Read Article →
CompanyMarch 2026

The Story Behind Aurora Analytica

After a decade leading feasibility operations across 400+ clinical studies, Co-founder & CEO Bhavish Lekh shares the journey from idea to platform — and what's next for Aurora Analytica.

Read Article →
CompanyNovember 2025

Aurora Analytica Welcomes Espen Gudmundsen as CTO

Espen Gudmundsen joins Aurora Analytica as Chief Technology Officer, bringing 10+ years of expertise in software development, AI, and cybersecurity.

Read Article →
CompanyOctober 2025

Aurora Analytica Awarded 1.2 Million NOK in Innovation Grants from Innovation Norway

Aurora Analytica™ has received a total of 1.2 million NOK in grants from Innovation Norway since 2024, accelerating development of the Aurora Suite™.

Read Article →
PublicationAugust 2025

Breaking Down Silos: A User-Defined Approach to Global Feasibility

How Aurora Analytica™ transforms fragmented data into connected, actionable clinical trial intelligence — going beyond siloed databases.

Read Article →
PublicationAugust 2025

Decision Engines™ vs Data Tools: Navigating Clinical Trials Smarter

Why a GPS beats hundreds of paper maps — exploring the difference between traditional data tools and Aurora's Decision Engines™.

Read Article →
CompanyMarch 2025

Aurora Analytica Recognized by the EIC for Its Ground-breaking Innovation

The European Innovation Council described the Aurora Suite as "a superior solution compared to existing fragmented systems" and a "highly novel, deep tech breakthrough."

Read Article →
CompanyMarch 2025

Aurora Analytica Awarded Innovation Norway Start-up 2 Grant

Aurora Analytica has been awarded the prestigious Start-up 2 grant from Innovation Norway, validating our technology and mission.

Read Article →
Case StudyMarch 2025

Delivering New Clinical Trial Wins for CROs

We supported a mid-size CRO through a full feasibility and strategy process, resulting in a won global clinical trial and an NPS of 9.1.

Read Article →
PublicationSep 2024

Optimizing Phase III Trials in Pancreatic Cancer – ESMO Poster 2024

Our ESMO 2024 poster showcases how the Aurora Suite™ optimizes Phase III trial strategy in pancreatic cancer — delivering 200%+ enrolment improvement and 80%+ time savings.

Read Article →